C

CVS Health

Runs pharmacies, health plans and clinics

Principal AI Architect

Full-TimeUpdated on 10/24/2026Deadline 12/31/26
$144.2k - $288.4k/yr+ Bonus + Commission + Short-term incentive + Equity award
Expert
Bachelor's
Colorado, USA
Remote
AI & Machine LearningApplied Machine Learning
Company Historically Provides H1B Sponsorship

About the job

Requirements
  • At least 12 years of experience in technology, including deep hands-on experience in AI/ML platform and solution architecture at Aetna Technology scale.
  • Expert-level command of model serving, multi-model orchestration, retrieval, and evaluation on cloud platforms; AWS is primary, with GCP or Azure familiarity preferred.
  • Demonstrated ownership of AI reference architectures and paved-road or golden-path patterns for model and agent development.
  • Hands-on experience designing agentic systems, including orchestration, tool and skill layers, and API and MCP integration patterns.
  • Strong grounding in responsible AI, model evaluation, and guardrail design.
  • A track record of driving technical outcomes through influence and design authority as an individual contributor.
  • A bachelor's degree in Computer Science, Engineering, or a related field, or equivalent experience.
Responsibilities
  • Own Aetna Technology AI reference architectures for model serving, multi-model orchestration, retrieval, and evaluation across AWS-primary and multicloud infrastructure.
  • Define the agentic architecture, including agent orchestration as the enforced contract, domain agents scoped by journey and business context, and a reusable skills layer.
  • Set the API-first integration default, define when MCP may be adopted by exception, and establish the criteria for exceptions.
  • Design and maintain the paved road and golden patterns for building, serving, and evaluating models and agents.
  • Embed guardrails, evaluation, and safety controls into the paved road so responsible-AI practices are inherited by default.
  • Define model evaluation and benchmarking practices for comparing, selecting, and retesting models as the landscape changes.
  • Establish controls for regulated and sensitive data, including PHI access, grounding, and blast-radius reduction across agents and models.
  • Define instrumentation linking AI investment to measurable outcomes, including the ledger, labor-redeployment signals, and usage telemetry expressed in dollar terms.
  • Partner with platform and finance teams on cost-aware AI architecture, making unit economics a first-class design constraint.
  • Author AI standards enforced as automated gates and paved-road defaults rather than a review queue.
  • Contribute to architecture governance through reference architectures, technology radar input, and design reviews in partnership with Enterprise Architecture.
  • Evaluate emerging models, frameworks, and agentic tooling and make directional adoption recommendations.
  • Translate AI architecture trade-offs into clear, decision-oriented narratives for senior technology leaders and peer architects.
  • Coach Solution Architects and senior engineers through design reviews and system-level reasoning without direct reporting relationships.
  • Act as a technical partner to strategic AI vendors and internal platform teams.
Desired Qualifications
  • Experience in healthcare, health insurance, or similarly regulated industries.
  • Familiarity with FinOps and cost-aware AI architecture, including tying design decisions to dollar impact.
  • Experience instrumenting AI return-on-investment and adoption metrics for executive audiences.
  • Experience with infrastructure-as-code and automated policy or guardrail enforcement.
  • Familiarity with GCP or Azure.

About the company

CVS Health runs pharmacies, health insurance plans and medical clinics for individuals, employers and government programs across the United States. Its businesses include CVS Pharmacy, the Aetna insurer and Caremark, which manages prescription coverage and negotiates drug prices for health plans. Patients fill prescriptions in stores or by mail and receive care through walk-in clinics, primary care centers and home visits. The company earns money from prescription sales, insurance premiums, plan administration fees and clinical services, combining coverage with places to obtain treatment. Its first store opened in 1963, and its headquarters are in Woonsocket, Rhode Island.

Company Size

10,001+

Company Stage

IPO

Headquarters

Woonsocket, Rhode Island

Founded

1963

Get referred to CVS Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Demand is expanding: CVS Health reported $106.1 billion revenue in the June 2026 quarter, up 7.3% year over year.
  • Eligible colleagues get degree support: CVS Health's partner-college program covers tuition with no out-of-pocket cost through reimbursement.
  • Self-pay care is expanding: MinuteClinic announced $29 online weight-loss visits in August 2026, without recurring membership fees.

What critics are saying

  • Insurance leaves a narrow cushion: Aetna's medical costs consumed 87.4% of premium revenue in the June 2026 quarter.
  • Drug fees face limits: Caremark's July 2026 FTC settlement proposes separating fees from drug list prices.
  • Wilmington's pharmacist role includes mobility: CVS Rx Services lists up to 25% travel across nearby pharmacy locations.

What makes CVS Health unique

  • Its pharmacy shelves are tobacco-free: CVS removed tobacco products while keeping its national retail pharmacy network.
  • Caremark separates drug costs from service fees: TrueCost anchors pricing to acquisition benchmarks and makes dispensing fees visible.
  • Its clinics accept care-cost risk: Oak Street receives fixed payments from health plans rather than billing only per visit.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Life Insurance
  • Disability Insurance
  • 401(k) Retirement Plan
  • Company Equity
  • Wellness Program
  • Professional Development Budget
  • Paid Vacation
  • Paid Holidays

Company News

Yahoo Finance
Oct 20th, 2026
CVS opens small 3,000 sq ft pharmacies to fill gaps left by 1,000 Walgreens and Rite Aid closures

CVS Health is opening small, pharmacy-only stores in communities left underserved after rivals closed locations. The chain has opened its newest 3,000-square-foot store in Roxbury, Massachusetts, just outside Boston. Walgreens and CVS have closed over 1,000 stores in recent years, and Rite Aid shut all 2,000 of its stores in 2023. Thinner margins strained profits at the chains. CVS plans to open 20 small-format stores this year. It already has sites in Birmingham, Chicago, Detroit, Houston, and Washington, D.C. Most offer immunisations as well as prescriptions. Smaller stores could cut inventory and rent costs. Walgreens has opened about 100 smaller stores for the same reason. IBISWorld puts the US pharmacy market at $739.4 billion in 2026.

PR Newswire
Oct 20th, 2026
MinuteClinic opens three Massachusetts clinics, including its first in Boston

CVS Health said MinuteClinic, its medical clinic inside select CVS Pharmacy stores, has opened three Massachusetts locations in Charlestown, Beverly, and Swampscott. The Charlestown clinic is the first MinuteClinic in Boston. Board-certified nurse practitioners staff each clinic. They offer vaccinations, health screenings, routine lab tests, physicals, and treatment for minor illnesses and injuries. Patients aged 18 months and older can walk in seven days a week, including evenings and weekends. Most major health insurance is accepted, and self-pay options are available. "By making care more accessible, we can help patients address health concerns earlier and avoid unnecessary visits to higher-cost settings such as the emergency room," said Tara Allain, executive area director at MinuteClinic.

Yahoo Finance
Oct 19th, 2026
CVS Health raises 2026 revenue forecast to $414B, but shares fall 11.5%

CVS Health raised its fiscal 2026 revenue forecast on August 5 to at least $414 billion, up from $405 billion in May. Yet the stock has fallen 11.5% since, against a 1.0% dip for the S&P 500. The company also lifted its adjusted earnings per share target to between $7.90 and $8.10, from $7.40 at the mid-point. It now expects cash flow from operations of at least $11.5 billion, up from $9.5 billion. Shares closed at $92.36 on October 16, just above the 50-day average of $91.73 and the 200-day average of $87.51. The new forecast implies second-half revenue about 0.5% below the same period last year. The next key test is the September quarter report, expected on November 4.

PR Newswire
Oct 7th, 2026
CVS Health opens first pharmacy-focused location in Boston area

CVS Health has opened its first pharmacy-focused location in the Boston area, situated at 32 Warren Street in Roxbury. The company plans to launch nearly 20 such locations across the US in 2026 to increase access to pharmacy care. The new format features full-service pharmacies averaging 3,000 square feet, offering prescription medications, immunisations, and over-the-counter products. Customers can order additional items with free home delivery. The Roxbury site includes a medication disposal bin and safe needle collection point. These smaller pharmacies complement CVS's existing formats, including traditional stores, store-in-store locations in Target and Schnucks, and sites with MinuteClinic facilities. According to CVS Health's 2025 Rx Report, 80% of patients prefer face-to-face pharmacy care, whilst 48% would switch pharmacies if limited to digital-only options.

Yahoo Finance
Sep 25th, 2026
CVS shares drop 15% as pharmacy giant warns of unquantified 340B business headwinds in 2027

CVS Health faces an unquantified headwind from its 340B drug discount programme heading into 2027, management warned during its fiscal Q2 2026 earnings call in August. The company's shares have fallen 15.2% over the past three months, even as management raised its 2026 earnings outlook. The 340B business, which serves eligible healthcare organisations, is experiencing pressure as drugmakers limit programme coverage. Management expects this drag to continue affecting its pharmacy services business in 2027 but declined to quantify the potential impact. CVS's Health Services segment, which likely includes the 340B business, generated $190.4 billion in revenue during fiscal 2025. The company trades at 22.5 times trailing earnings, roughly level with the S&P 500's 22.4 multiple.